FDA will drop two-study requirement for new drug approvals
FDA will drop two-study requirement for new drug approvals is drawing significant interest across the industry.
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to win approval of new drugs, the agency's leaders said.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- 415 students land jobs during campus drive in Tirupati
- At least 17 killed, 18 injured in Nagpur factory blast
- Neanderthals seemed to have a thing for modern human women
- Google launches Nano Banana 2 model with faster image generation
Source: Original →